Related references
Note: Only part of the references are listed.KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero et al.
HAEMATOLOGICA (2020)
Overexpression of BUB1B, CCNA2, CDC20, and CDK1 in tumor tissues predicts poor survival in pancreatic ductal adenocarcinoma
Shu Dong et al.
BIOSCIENCE REPORTS (2019)
Identification of specific modules and hub genes associated with the progression of gastric cancer
Congcong Gong et al.
CARCINOGENESIS (2019)
Investigation of the synergistic effects of paclitaxel and herbal substances and endemic plant extracts on cell cycle and apoptosis signal pathways in prostate cancer cell lines
Zeynep Ozlem Dogan Sigva et al.
GENE (2019)
High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma
Qin Jin et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Co-expression Network Analysis Identifies Four Hub Genes Associated With Prognosis in Soft Tissue Sarcoma
Zhenhua Zhu et al.
FRONTIERS IN GENETICS (2019)
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma
Chengtao Sun et al.
BIOSCIENCE REPORTS (2019)
Aneuploid acute myeloid leukemia exhibits a signature of genomic alterations in the cell cycle and protein degradation machinery
Giorgia Simonetti et al.
CANCER (2019)
MicroRNA-144 inhibits cell proliferation, migration and invasion in human hepatocellular carcinoma by targeting CCNB1
Junsheng Gu et al.
CANCER CELL INTERNATIONAL (2019)
PUF60 accelerates the progression of breast cancer through downregulation of PTEN expression
Dongying Sun et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Mantle cell lymphoma and its management: where are we now?
Abdullah Ladha et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2019)
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial
Riccardo Bomben et al.
HAEMATOLOGICA (2018)
Dihydrocelastrol exerts potent antitumor activity in mantle cell lymphoma cells via dual inhibition of mTORC1 and mTORC2
Yongsheng Xie et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction
Hung-Chuan Chiu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: results from the Fondazione Italiana Linfomi MCL-0208 trial
Riccardo Bomben et al.
HAEMATOLOGICA (2018)
Upregulation of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in Tumor Tissues Predicted Worse Overall Survival and Disease-Free Survival in Hepatocellular Carcinoma Patients
Liping Zhuang et al.
BIOMED RESEARCH INTERNATIONAL (2018)
CREPT/RPRD1B associates with Aurora B to regulate Cyclin B1 expression for accelerating the G2/M transition in gastric cancer
Lidan Ding et al.
CELL DEATH & DISEASE (2018)
CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer
Yaqi Gan et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
The 2016 updated WHO classification of lymphoid neoplasias
Leticia Quintanilla-Martinez
HEMATOLOGICAL ONCOLOGY (2017)
Cdc20 directs proteasome-mediated degradation of the tumor suppressor SMAR1 in higher grades of cancer through the anaphase promoting complex
Debasish Paul et al.
CELL DEATH & DISEASE (2017)
Kinesin family member 11 contributes to the progression and prognosis of human breast cancer
Yuan-Yuan Pei et al.
ONCOLOGY LETTERS (2017)
The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis
Yong Wen et al.
ONCOTARGET (2017)
Kinesin Family Member 11 mRNA Expression Predicts Prostate Cancer Aggressiveness
Xuan-Mei Piao et al.
CLINICAL GENITOURINARY CANCER (2017)
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
AMERICAN JOURNAL OF HEMATOLOGY (2017)
PF-04691502, a dual PI3K/mTOR inhibitor has potent pre-clinical activity by inducing apoptosis and G1 cell cycle arrest in aggressive B-cell non-Hodgkin lymphomas
Deyu Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP (vol 23, pg 618, 2013)
Min Lu et al.
CANCER CELL (2016)
Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patients
Sohei Kobayashi et al.
ONCOTARGET (2016)
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Tadeusz Robak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pathogenic mechanisms of lung adenocarcinoma in smokers and non-smokers determined by gene expression interrogation
Yunqian Hu et al.
ONCOLOGY LETTERS (2015)
Hijacked in cancer: the KMT2 (MLL) family of methyltransferases
Rajesh C. Rao et al.
NATURE REVIEWS CANCER (2015)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
WGCNA: an R package for weighted correlation network analysis
Peter Langfelder et al.
BMC BIOINFORMATICS (2008)